Related Experiment Video
Updated: Jul 5, 2026

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Signal transduction pathways
1CRC Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, UK. lloyd@icr.ac.uk
Abstract:
The development of agents designed to interfere with the various signal transduction pathways known to be aberrant in cancers remains an interesting area of anticancer drug development. The ability to identify a large series of kinase inhibitors with differing selectivities has been one of the major recent advances in medicinal chemistry. A series of first generation inhibitors of cyclin-dependent kinases, specific tyrosine kinases, (as well as inhibitors of processing of the Ras protein, which were not covered in this session) have now reached early clinical trials. In contrast to trials with "standard" cytotoxic agents, cytostatic effects necessitating the use of chronic, ideally oral, dosing schedules is the norm for these new agents.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers
Signal Transduction: Overview
Typically, signal transduction involves three...
Intracellular Signaling Cascades
Intracellular Signaling Cascades
Amplifying Signals via Enzymatic Cascade

